Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Effects of divalproex on smoking cue reactivity and cessation outcomes among smokers achieving initial abstinence.

Ditre JW, Oliver JA, Myrick H, Henderson S, Saladin ME, Drobes DJ.

Exp Clin Psychopharmacol. 2012 Aug;20(4):293-301. doi: 10.1037/a0027789. Epub 2012 Apr 2.

2.

Cue reactivity as a predictor of successful abstinence initiation among adult smokers.

Conklin CA, Parzynski CS, Salkeld RP, Perkins KA, Fonte CA.

Exp Clin Psychopharmacol. 2012 Dec;20(6):473-8. doi: 10.1037/a0029599. Epub 2012 Aug 13.

3.
4.

Severity of dependence modulates smokers' neuronal cue reactivity and cigarette craving elicited by tobacco advertisement.

Vollstädt-Klein S, Kobiella A, Bühler M, Graf C, Fehr C, Mann K, Smolka MN.

Addict Biol. 2011 Jan;16(1):166-75. doi: 10.1111/j.1369-1600.2010.00207.x.

PMID:
20331560
5.

Effects of varenicline on smoking cue–triggered neural and craving responses.

Franklin T, Wang Z, Suh JJ, Hazan R, Cruz J, Li Y, Goldman M, Detre JA, O'Brien CP, Childress AR.

Arch Gen Psychiatry. 2011 May;68(5):516-26. doi: 10.1001/archgenpsychiatry.2010.190. Epub 2011 Jan 3.

6.

Cue-provoked craving and nicotine replacement therapy in smoking cessation.

Waters AJ, Shiffman S, Sayette MA, Paty JA, Gwaltney CJ, Balabanis MH.

J Consult Clin Psychol. 2004 Dec;72(6):1136-43.

PMID:
15612859
7.

Evidence for greater cue reactivity among low-dependent vs. high-dependent smokers.

Watson NL, Carpenter MJ, Saladin ME, Gray KM, Upadhyaya HP.

Addict Behav. 2010 Jul;35(7):673-7. doi: 10.1016/j.addbeh.2010.02.010. Epub 2010 Feb 17.

8.

Effects of transdermal nicotine patches on abstinence-induced and cue-elicited craving in cigarette smokers.

Tiffany ST, Cox LS, Elash CA.

J Consult Clin Psychol. 2000 Apr;68(2):233-40.

PMID:
10780123
9.

Transdermal nicotine during cue reactivity in adult smokers with and without anxiety disorders.

Morissette SB, Gulliver SB, Kamholz BW, Spiegel DA, Tiffany ST, Barlow DH.

Psychol Addict Behav. 2012 Sep;26(3):507-18. doi: 10.1037/a0028828. Epub 2012 Jun 11.

10.

Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.

Aubin HJ, Lebargy F, Berlin I, Bidaut-Mazel C, Chemali-Hudry J, Lagrue G.

Addiction. 2004 Sep;99(9):1206-18.

PMID:
15317642
11.

The efficacy and safety of a nicotine conjugate vaccine (NicVAX®) or placebo co-administered with varenicline (Champix®) for smoking cessation: study protocol of a phase IIb, double blind, randomized, placebo controlled trial.

Hoogsteder PH, Kotz D, van Spiegel PI, Viechtbauer W, Brauer R, Kessler PD, Kalnik MW, Fahim RE, van Schayck OC.

BMC Public Health. 2012 Dec 6;12:1052. doi: 10.1186/1471-2458-12-1052.

12.

Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study.

Goudriaan AE, de Ruiter MB, van den Brink W, Oosterlaan J, Veltman DJ.

Addict Biol. 2010 Oct;15(4):491-503. doi: 10.1111/j.1369-1600.2010.00242.x. Epub 2010 Sep 14.

13.

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders.

Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, Fava M.

J Clin Psychopharmacol. 2008 Dec;28(6):660-6. doi: 10.1097/JCP.0b013e31818ad7d6.

14.

Effects of D-cycloserine on cue-induced craving and cigarette smoking among concurrent cocaine- and nicotine-dependent volunteers.

Yoon JH, Newton TF, Haile CN, Bordnick PS, Fintzy RE, Culbertson C, Mahoney JJ 3rd, Hawkins RY, Labounty KR, Ross EL, Aziziyeh AI, De La Garza R 2nd.

Addict Behav. 2013 Feb;38(2):1518-26. doi: 10.1016/j.addbeh.2012.03.022. Epub 2012 Mar 26.

15.

[Smoking reduction and temporary abstinence: new approaches for smoking cessation].

Le Houezec J, Säwe U.

J Mal Vasc. 2003 Dec;28(5):293-300. Review. French.

PMID:
14978435
16.

Cue exposure and response prevention with heavy smokers: a laboratory-based randomised placebo-controlled trial examining the effects of D-cycloserine on cue reactivity and attentional bias.

Kamboj SK, Joye A, Das RK, Gibson AJ, Morgan CJ, Curran HV.

Psychopharmacology (Berl). 2012 May;221(2):273-84. doi: 10.1007/s00213-011-2571-2. Epub 2011 Nov 22.

PMID:
22101394
17.

Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.

Brody AL, Mukhin AG, Mamoun MS, Luu T, Neary M, Liang L, Shieh J, Sugar CA, Rose JE, Mandelkern MA.

JAMA Psychiatry. 2014 Jul 1;71(7):797-805. doi: 10.1001/jamapsychiatry.2014.138.

18.

Cue reactivity in converted and native intermittent smokers.

Shiffman S, Dunbar MS, Kirchner TR, Li X, Tindle HA, Anderson SJ, Scholl SM, Ferguson SG.

Nicotine Tob Res. 2015 Jan;17(1):119-23. doi: 10.1093/ntr/ntu147. Epub 2014 Aug 28.

19.

Subjective reactivity to smoking cues as a predictor of quitting success.

Perkins KA.

Nicotine Tob Res. 2012 Apr;14(4):383-7. doi: 10.1093/ntr/ntr229. Epub 2011 Dec 1.

20.

Peak provoked craving: an alternative to smoking cue-reactivity.

Sayette MA, Tiffany ST.

Addiction. 2013 Jun;108(6):1019-25. doi: 10.1111/j.1360-0443.2012.04013.x. Epub 2012 Oct 17.

Supplemental Content

Support Center